uniQure N.V. Ordinary Shares vs Stellantis N.V. Common Shares — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B), while Stellantis N.V. Common Shares trades at $4.27 (market cap $16.20B). The key difference: Stellantis N.V. Common Shares is far larger — about 11.2× uniQure N.V. Ordinary Shares's market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Stellantis N.V. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Stellantis N.V. Common Shares for 0 Days on average.
| QURE | STLA | |
|---|---|---|
Market Cap | $1.45B | $16.20B |
Volume | 3,323,243 | 30,607,418 |
Sector | Health | Consumer Cyclical |
52-Week High | $70.59 | $12.12 |
52-Week Low | $9.03 | $4.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $707.46M | $35.94B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →Stellantis N.V. is a multinational automaker formed from the 2021 merger of Fiat Chrysler Automobiles and PSA Group, manufacturing vehicles under brands including Jeep, Ram, Chrysler, Dodge, Fiat, Peugeot, and Citroën.
Read more on STLA →